Synthesis, characterization and antimicrobial activity of Schiff base complexes of Cu (II) and Ni (II)
K.L.P. Sheeja Lovely*, M. Christudhas
Department of Chemistry, N.M. Christian College, Marthandam -629165, India.
Corresponding Author E-mail: arrvinvin@yahoo.co.in.
ABSTRACT:
The Schiff base complexes of Cu (II) and Ni (II) derived from 3-pyridine carboxaldehyde with histidine and tryptophan have been synthesized and characterized by elemental analysis, FT - IR and magnetic susceptibility measurements. The Schiff base and its metal complexes show a good activity against the bacteria; Klebsiella pneumonia, Pseudomonas aeroginosa, E.coli, Staphylococcus aureus, Proteus and fungi Aspergillus niger. The antimicrobial results also indicate that the metal complexes are better antimicrobial agents as compared to the Schiff bases.
KEY WORDS: 3 - Pyridine carboxaldehyde, Histidine, Tryptophan, Antimicrobial activity, Spectral studies.
INTRODUCTION:
Metal complexes play an essential role in agriculture, pharmaceutical and industrial chemistry. Ligand, a metal surrounded by a cluster of ions or molecules is used for the preparation of complex compounds named as Schiff base1 which are condensation products of primary amines and aldehydes or ketones.
The Schiff bases are widely studied because of increasing recognition of their role in biological systems2, 3. Their complexes have been studied for their interesting and important properties such as complexing ability towards some toxic metals4, their ability to reversibly bind oxygen5. The interaction between metal ions and amino acids is of considerable interest as metals for metal - protein reactions and models in a variety of biological systems6. Schiff base complexes have remained an important and popular area of research due to their simple synthesis, versatility and diverse range of applications7. Many potent antibacterial and antifungal Schiff base compounds were reported8 - 11. Some heterocyclic Schiff bases12 - 14 can act as antibacterial agent.
This paper describes the synthesis, characterization and antimicrobial studies of Schiff base complexes of 3-pyridine carboxaldehyde and amino acids. The amino acids used were histidine and tryptophan.
The resulting complexes were studied by magnetic measurements and IR spectra. The new Schiff base and its complexes were tested for antibacterial activity against pathogenic bacterial species. Klebsiella Pneumonia, Pseudomonas aeroginosa, E.Coli, Staphylococcus aureus, Proteus and also for antifungal activity against Aspergillus niger.
MATERIALS AND METHODS:
MATERIALS
All the chemicals and solvents used were of A R grade. All the reagents used for the preparation of the Schiff bases were obtained from Sigma Aldrich. Metal salts were purchased from Loba Chemie.
Elemental analyses of the ligand and complexes were done on a Perkin-Elemer 240 analyzer. IR spectra of the ligands and their complexes have been recorded in KBr pellets at Shimadzu FT – IR 8201 spectrophotometer in 4000 – 200 cm‑1. Magnetic susceptibility measurements on powder form of the complexes were recorded with a Gouy’s balance by using mercuric tetrathiocyanato cobaltate (II) as a calibrant at 250C.
General procedure for preparation of Schiff bases
Schiff bases have been synthesized by adding the methanolic solution of aldehyde with amino acids in equimolar ratio. The reaction mixture was then refluxed on a water bath for about 4 - 5 hrs. The condensation product was filtered, thoroughly washed with ethanol, ether and dried in vacuum.
General procedure for preparation of metal complexes
All the complexes were prepared by mixing hot ethanolic solution of Schiff base ligand with the corresponding metal salts with constant stirring. The resulting mixture was refluxed on a water bath for about 6 – 12 hrs. A coloured product appeared on standing and cooling the solution. The complexes were filtered, washed with ether and dried under reduced pressure over anhydrous CaCl2.
Preparation of Schiff base
i) 3-Pyridine carboxaldehyde with histidine (L1)
Ligand (L1)
Scheme - 1
ii) 3-pyridine carboxaldehyde with Tryptophan (L2)
Ligand (L1)
Scheme – 2
Preparation of metal complexes
Hot methanolic solution of ligand L1, L2 (0.05 mol) and hot methanolic solution of the Cu (II), Ni (II) metal salts (0.05 mol) were mixed with stirring. The mixture was refluxed for 2 – 3 hours at 70 – 800 C on a water bath. On cooling coloured solid metal complex were precipitated out. The product was filtered, washed with cold methanol and dried under vacuum over P4O10.
Biological activity
The invitro biological activity of the Schiff base and its metal complexes were tested against the bacteria Klebsiella pneumonia, Pseudomonas aeroginosa, E. Coli, Staphylococcus aureus and Proteus by disc diffusion method using nutrient agar as medium and Amikacin as control. The antifungal activities of the compounds were also tested by the invitro well diffusion method against the fungi Aspergillus niger on potato dextrose agar as the medium and Flucanazole as control. Each of the compounds was dissolved in dimethyl sulfoxide and solutions of the concentrations were prepared separately. In a typical procedure, a well was made on agar medium inoculated with microorganisms. The well was filled with the test solution using a micro pipette and the plate was incubated 24 hrs for bacteria at 370C and 72 hrs for fungi at 300C. During this period, the test solution diffused and the growth of the inoculated microorganisms was affected. The inhibition zone was developed at which the concentration was noted.
RESULT AND DISCUSSION:
All the complexes are stable at room temperature, non - hygroscopic, insoluble in water but slightly soluble in methanol and ethanol and soluble in DMF and DMSO.
Elemental Analysis:
The Schiff base and metal complexes are subjected to elemental analysis. The results of elemental analysis (C, H and N) with molecular formula are presented in Table. 1 The results obtained are in good agreement with those calculated for suggested formula.
The results of the selected IR measurements were tabulated in Table II.
The free Schiff base show the characteristic of 3 - substituted pyridine ring (774 cm-), imino group – C = N
( 1590 cm-1 ), –
– group in the acid (
1631 cm-1 ), free – OH group of the carboxyl group ( 3319 cm-1
). The IR spectrum of the ligand is compared with the spectra of complexes
(fig. 1 and 2). The presence of
bond
of the imidazole ring at 3063 cm-1 confirms the unbounded nature of
the NH group. The C = N bond 1590 cm-1 is shifted to lower frequency
suggesting coordination of both the N atoms to metal. Another absorption band
at 1022.96cm-1 is assigned to the coordinated nitrato group with the
central metal atom. The absorption band around 3319 cm-1 is assigned
to the free OH group of the carboxyl group.
Table. 1 Analytical and physical data of Schiff base and its complexes.
|
Compound |
Colour Yield (%) |
M.P (°C) |
Calculated (found) % |
eff (BM) |
||
|
C |
H |
N |
|
|||
|
Ligand (L1) C12 H12 N4 O2 |
White (65) |
188 |
59.02 (59.28) |
4.91 (4.61) |
22.95 (22.61) |
– |
|
[Cu L1 (NO3)2] |
Bluish Green (50) |
212 |
33.41 (33.20) |
2.78 (2.60) |
19.48 (19.76) |
1.8 |
|
[Ni L1 (NO3)2] |
light green (45) |
217 |
33.72 (33.51) |
2.81 (2.98) |
19.67 (19.99) |
3.1 |
|
Ligand (L2) C17 H15 N3 O2 |
White (70) |
194 |
69.62 (69.39) |
5.12 (5.00) |
14.33 (14.20) |
– |
|
[Cu L2 (NO3)]2 |
Blue (55) |
210 |
42.5 (42.30) |
3.12 (3.28) |
14.58 (14.30) |
2.0` |
|
[Ni L2 (NO3)]2 |
Golden yellow (53) |
216 |
42.86 (43.10) |
3.15 (3.01) |
14.70 (14.41) |
2.9 |
Fig 1: FTIR spectrum of Schiff base ligand (L1)
Fig 2: FTIR spectrum of Ni (II) complex of ligand (L1)
INFRARED SPECTRA
Based on the above following structure is proposed Fig [3].
Table: II Selected FT – IR frequencies (cm1) of the ligand and complexes
|
Ligand/Complex |
C = N |
C O |
c H |
M N |
|
L1 |
1590 |
1631 |
3319 |
- |
|
[CuL1(NO3)2] |
1449 |
1600 |
3319 |
1022 |
|
[NiL1(NO3)2] |
1402 |
1598 |
3303 |
1015 |
M = Cu(II) , Ni(II)
The IR spectral data of the ligand and the complexes are given in Table III. From the IR spectrum of the ligand, the absorption band at 681 cm-1 is due to the ring bending of 3 – substituted pyridine. The absorption band at 1577 cm-1 is due to the absorption of imino group (– CH = N ). The absorption band around 3401 cm-1 is due to the free OH of the carboxylic acid. The presence of – C – group in the acid is confirmed by the absorption at 1655 cm-1. The FTIR spectrum of the ligand is compared with the spectra of complexes (fig. 4 and 5). The absorption bonds at 1655 cm-1, 1577 cm-1 are assigned to – C – , – CH = N – bonds respectively. The absorption at 1021 cm-1 is due to the coordination of nitrato group with central metal atom15. The – C = N – band 1577 cm‑1 is shifted to lower frequency suggesting coordination of both the N atoms to metal. Based on the above following structure is proposed to the metal complexes fig 6.
Table: III Selected FI – IR frequencies (cm1) of the ligand and complexes
|
Ligand/Complex |
C = N |
C O |
c H |
M N |
|
L2 |
1577 |
1655 |
3401 |
- |
|
[CuL2(NO3)2] |
1577 |
1655 |
3319 |
1021 |
|
[NiL2(NO3)2] |
1450 |
1655 |
3150 |
660 |
Fig : 3: Prosposed structure of Schiff base complexex of Cu(II) and Ni(II)
Fig 4: FTIR spectrum of Schiff base ligand (L2)
Fig 5: FTIR spectrum of Ni(II) complexe of ligand (L2)
Table IV: Antimicrobial activities of ligand
|
Ligand |
Antibacterial Activity (mm) |
Antifungal Activity (mm) |
||||
|
Klebsiella pneumonia |
Pseudomonas aeroginosa |
E. Coli |
Staphylococcus aureus |
Proteus |
Aspergillus niger |
|
|
L1 |
8 |
9 |
10 |
7 |
9 |
9 |
|
L2 |
9 |
10 |
9 |
7 |
10 |
10 |
|
Amikacin |
20 |
25 |
18 |
28 |
23 |
- |
|
Flucanazole |
- |
- |
- |
- |
- |
28 |
Table: V Antimicrobial activities of the complexes
Table V
|
Ligand / Complex |
Antibacterial Activity |
Antifungal Activity |
||||
|
Klebsiella pneumonia |
Pseudomonas aeroginosa |
E. Coli |
Staphylococcus aureus |
Proteus |
Aspergillus niger |
|
|
[CuL1(NO3)2] |
8 |
11 |
9 |
10 |
8 |
11 |
|
[NiL1(NO3)2] |
10 |
7 |
12 |
10 |
7 |
6 |
|
[CuL2(NO3)2] |
9 |
7 |
8 |
10 |
9 |
10 |
|
[NiL2(NO3)2] |
10 |
9 |
11 |
11 |
10 |
10 |
|
Amikacin |
20 |
25 |
18 |
28 |
23 |
- |
|
Flucanazole |
- |
- |
- |
- |
- |
28 |
The activity index value of the ligands are given in the table VI
Table VI
|
Ligand |
Antibacterial Activity |
Antifungal Activity |
||||
|
Klebsiella pneumonia |
Pseudomonas aeroginosa |
E. Coli |
Staphylococcus aureus |
Proteus |
Aspergillus niger |
|
|
L1 |
40 |
36 |
55 |
25 |
39 |
32 |
|
L2 |
45 |
40 |
50 |
25 |
43 |
36 |
|
Amikacin |
20 |
25 |
18 |
28 |
23 |
- |
|
Flucanazole |
- |
- |
- |
- |
- |
28 |
The activity index value of the complexes are given in the table VII
Table VII
|
Complex |
Antibacterial Activity |
Antifungal Activity |
||||
|
Klebsiella pneumonia |
Pseudammas aeroginosa |
E.Coli |
Staphylococcus aureus |
Proteus |
Aspogillus niger |
|
|
[CuL1 (NO3)2] |
40 |
44 |
50 |
36 |
35 |
39 |
|
[NiL1 (NO3)2] |
50 |
28 |
66 |
36 |
30 |
21 |
|
[CuL2 (NO3)2] |
45 |
28 |
44 |
36 |
39 |
36 |
|
[NiL2 (NO3)2] |
50 |
36 |
61 |
39 |
43 |
36 |
|
Amikacin |
20 |
25 |
18 |
28 |
23 |
- |
|
Flucanazole |
- |
- |
- |
- |
- |
28 |
Fig 6: Proposed structure of schiff base complex of Cu(II) and Ni(II) M = Cu(II), Ni(II)
The results of the antibacterial and antifungal screening of the Schiff base and the metal complexes with Klebsiella pneumonia, Pseudomonas aeroginosa, E.Coli, Staphylococcus aureus and Aspergillus niger by disc diffusion method are given in the table (IV and V).
The antibacterial activity was estimated based on the size of inhibition zone in the discs 16-19. Test drug solution of (100 g) of each compound was prepared by dissolving 1 mg of each compound separately in 1 ml of DMSO. Standard antibiotic Amikacin 5 g/disc was used as standard for bacteria. Standard antibiotic Amikacin 5 g/disc was used as standard for fungi.
The result of antibacterial activity substantiate the findings of earlier researches20-21 that biologically inactive compounds become active and less biologically active compounds become more active upon coordination. Such enhancement in biological activity of metal complexes canbe explained on the basis of Overtone's concept and Chelation theory22.
The ligand L1 shows highest antibacterial activity with the zone of inhibition 10mm against E-coli, whereas the antibacterial activity was a minimum with the zone of inhibition 7mm against staphylococcus for the same ligand.
The ligand L2 shows maximum antibacterial activity with the zone of inhibition 10mm against Pseudomonas aeroginosa, Proteus and minimum for Staphylococcus. By comparing ligand L1 and L2 towards anti fungal activity, ligand L2 shows maximum zone of inhibition 10mm against Aspergillus niger.
The Cu (II) Complex of Ligand L1 shows highest antibacterial activity with the zone of inhibition 11 mm against Pseudomonas aeroginosa and lowest activity with zone of inhibition 8mm against Klebsiella pneumonia and Proteus. The Ni(II) complex of ligand L1 shows higher antibacterial activity with the zone of inhibition 12mm against E.Coli and lowest activity with zone of inhibition 7mm against Pseudomonas aeroginosea and proteus. The Cu (II) Complex of Ligand L2 shows highest antibacterial activity with the zone of ibhibition 10 mm against Staphylococcus aureus and minimum zone of inhibition 7mm against Pseudomonas aeroginosa. The Ni (II) complex of ligand L2 shows highest antibacterial activity with the zone of inhibition 11 mm against E.Coli and Staphylococcus aureus and minimum zone of inhibition 9mm against Pseudomonas aeroginosa.
By comparing the above four complexes Cu (II) complex of ligand L1 shows highest anti fungal activity of the zone of inhibition 11mm against Aspergillus niger.
All the ligands and complexes were active against Klebsiella pneumonia, Pseudomonas aeroginosa, E.Coli, Staphylococcus aureus and Aspergillus niger due to the presence of pyridine ring, imidazole ring, indole ring, N = CH group metal ion.
The result was also expressed by means of activity index.
Activity Index = ![]()
CONCLUSION:
Cu (II), Ni(II) complexes of the Schiff base derived from 3 - pyridine carboxaldehyde and histidine, 3 - pyridine carboxaldehyde and tryptophand were prepared and characterized. The study reveals that Cu (II), Ni(II) complexes have Octahedral geometry.
The antimicrobial studies reveal that the compounds possess Significant activity against all the tested organisms.
REFFERENCES:
1. J.A. Mccleverty, T.J. Meyer Comprehensive Coordination Chemistry II, from Biology to Nanotechnology, Vol.1, Elsevier, p.411. (2004).
2. A. Mederos, S. Daminguz, R.Hernandez-Molina, J.Sanchiz, F.Brito, Coord,Chem. Rev. 193-195, 857-911, (1999).
3. W.J. Sawodny, M.Reiderer, Angew.Chem., Int.Edn. Engl.16. 859 (1977).
4. R.D. Jones, D.A. Summer Ville, F. Basolo, Chem. Rev. 79, 139 (1979).
5. M.M. Shoukry, R. Koussini, Bull. Soc. Chim. Fr. 128, 465 (1991).
6. Yamada, S. Coord. Chem. Rev 192, 537 (1999).
7. Z. H Chohan, A. Rouf, C.T. Supuran, Metal Based Drugs, 8, 287 (2002).
8. G.G. Mohamed, M.M. Omar, A.M.M. Spectrochim. Actapart A, 62, 1140 (2005).
9. A. Scozzafava, L. Menabuoni, F. Mincione, G. Mincione, C.T. Supran, Bioorg. Med. Chem. Lett. 11, 575 (2001).
10. M.S Sastry, R. Ghose, A, K. Ghose, Bull. Chem. Soc. Ethiop. 4, 61 (1990).
11. N. Raman, S. Thalamuthu, J. Dhaveethuraja, M.A. Neelakandan, S.J. Banerjee, Chil. Chem. soc. 53, 21 (2008).
12. V. Mishra, D.K. Sena, M.C. Jain, Synth React Inorg Met Org Chem 17 987 – 1002 (1987).
13. S.R. Bhusare, V.G. Pawar, S.B. Shinde, R.P. Pawer, & Y.B. Vibhute, Int. J. Chem. Sci, 1, 31 – 36 (2003). Chem Abstr, 140, 357246 (2004).
14. K. Singh, M.S. Barwa. & P. Tyagi U: Eur. J. Med chem., 41, 147 – 153 (2006).
15. S.G. Devi, P. Indrasenan, Inorg, Chem. Acta, 133, 157, (1987).
16. P.K. Mukherjee, K. Saha, S.M. Giri, M. Pal and B.P. Saha, Indian. J. Microbiol., 35, 327 (1995).
17. S. Gopalakrishnan, N.T. Nevaditha and C.V. Mythili., J. Chem. Pharm. Res. 3 (4), 490 (2011).
18. Z.H. Chohan, H. Pervez, A. Rauf, K.M. Khan, G.M. Maharvi and C.T. Supuram, J. Enz. Inhib. Med. Chem. 19, 417 (2004).
19. Z.H. Chohan, H. Pervez, A. Rauf, K.M. Khan, G.M. Khan, G.M. Maharvi and C.T. Supuram, J. Enz . Inhib. Med. Chem. 19, 417 (2004).
20. M. Li. June, Med. Resear. Rev. 23, 697 (2003).
21. I.B Afana seva, E.A. Ostrakhovitch, E.A. Mikhalachik, G.A. Ibragimova and L.G. Korkina, Biochem. Pharmacol. 61 677 (2001).
22. L. Mishra and V.K. Singh, Indian J. Chem., 32 A, 446 – 457 (1993).
Received on 18.08.2012 Modified on 05.09.2012
Accepted on 09.09.2012 © AJRC All right reserved
Asian J. Research Chem. 5(9): September, 2012; Page 1143-1149